A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer

por Shamash, J, Davies, A, Ansell, W, Mcfaul, S, Wilson, P, Oliver, T, Powles, T
Publicado 2008

Chlorambucil and lomustine (CL56) in absolute hormone refractory prostate cancer: re-induction of endocrine sensitivity an unexpected finding

por Shamash, J, Dancey, G, Barlow, C, Wilson, P, Ansell, W, Oliver, R T D
Publicado 2005

IPM chemotherapy in cytokine refractory renal cell cancer

por Shamash, J, Steele, J P, Wilson, P, Nystrom, M, Ansell, W, Oliver, R T D
Publicado 2003

GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours

por Shamash, J, Powles, T, Ansell, W, Stebbing, J, Mutsvangwa, K, Wilson, P, Asterling, S, Liu, S, Wyatt, P, Joel, S P, Oliver, R T D
Publicado 2007

GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours

por Shamash, J, Powles, T, Ansell, W, Berney, D, Stebbing, J, Mutsvangwa, K, Wilson, P, Asterling, S, Liu, S, Wyatt, P, Joel, S P, Oliver, R T D
Publicado 2007